CDSCO Cancels Skintl Enterprises' Cosmetic Import Registrations Over Unregistered Products, Labelling Violations

Written By : Susmita Roy Published On 2026-09-04T20:15:15+05:30 | Updated On 4 Sept 2026 8:15 PM IST

Rajasthan NEET UG Counselling Board Cancels 100 MBBS Students

New Delhi: The Central Drugs Standard Control Organization (CDSCO) has cancelled three cosmetic import registration certificates held by Skintl Enterprises after an investigation found alleged regulatory violations, including the stocking of products without valid registration certificates, the use of incorrect registration certificate numbers on product labels, and the shifting of its warehouse without prior intimation to or approval from the licensing authority.

The cancellation was ordered by CDSCO’s Cosmetics Division through an order dated August 24, 2026. The order, bearing File No. COS-11012/5/2026-eoffice, concerns unregistered cosmetic products allegedly sold through online e-commerce platforms.

Skintl Enterprises Pvt. Ltd A-150-151, Road No 4, Gali No.-9, Mahipalpur Extn. Delhi lndia Pin code-1 10037 had registered cosmetics products for import vide Registration Certificate no. vide RC/COS-005535 dated 25-Oct-2Q24 valid upto 24-Oct-2029, RC/COS-006751 dated 17-Dec-2025valid up o 16-Dec-2030 and IRN/COS44/2025/000039 dated 17-Nov-2025.

An investigation was conducted at the premises of the firm of M/s Skintl Enterprises Pvt. Ltd on 30.03.2026, in connection with the complaint regarding the sale of cosmetic products through various e-commerce platforms and their own retail outlets.

Also Read:Health Ministry Restricts Chlorpheniramine-Phenylephrine FDCs for Children Below 4, Mandates Warning Labels

The firm was found to have mentioned incorrect Registration Certificate numbers on product labels, and multiple products were found stocked without valid Registration Certificates. Further, it was observed that the firm had shifted its warehouse premises without prior intimation or approval from the licensing authority. In addition to the above, several other deficiencies and non-compliances were also reported by the joint investigation team in the investigation report dated 09.04.2026.

Referring to the statutory requirements governing the import and labelling of cosmetics, CDSCO cited Section 10(b) of the Drugs and Cosmetics Act, 1940. As per Section 10 (b) of Drug & Cosmetics Act, 1940, from such date as may be fixed by the Central Government by notification in the Official Gazette in this behalf, no person shall import- (b) any misbranded drug [or misbranded or spurious cosmetic].

The regulator also referred to Rule 12(1) of the Cosmetics Rules, 2020,which provides that no cosmetic shall be imported into India unless the product has been registered in accordance with these rules by the Central Licensing Authority.

CDSCO further invoked Rule 15(3) of the Cosmetics Rules, 2020.. As per Rule 15 (3) of the Cosmetics Rules, 2020, in case of a change in name or address of a registration holder or overseas manufacturer, after grant of registration under sub-rule ('1) of rule '13, an application for amendment shall be made in online portal of central government for prior approval from the central Licensing Authority for the said changes in registration certificate within a period of sixty days from the date of such change.

The order also cited Rules 34 and 35 of the Cosmetics Rules, 2020. According to the provisions of Rule 34, Manner of labelling and Rule 35 of the Cosmetics Rules, 2020, no person shall alter, obliterate or deface any inscription or mark made or recorded by the manufacturer on the container, label or wrapper of any cosmetic.

It further added, that according to provisions of the Cosmetics Rules, 2020, as per Condition No. 3 of the RC issued under Form COS-2, the manufacturer or his authorised agent or importer or distributor or subsidiary in India shall inform the Licensing Authority within thirty days, in writing, in the event of change in labelling or composition or testing, or specification, or in documentation of any of the cosmetics pertaining to this RC, along with an undertaking that the products comply with standards laid down by the Bureau of Indian Standards as referred to in the Ninth Schedule.

The order further stated that a show-cause notice (SCN) dated 27.04.2026 was issued to the firm for the violations of Section 10 (b) of the Drug & Cosmetics Act, 1940, Rule 12 (1), Rule 15 (3), Rule 34 and Rule 35 of the Cosmetics Rules, 2020, and Condition No. 3 of the Registration Certificate granted by this Directorate.

The firm has submitted its response dated 30.06.2026, wherein the firm has acknowledged the violations observed in the matter.

After considering the investigation findings and the company’s response, the licensing authority decided to cancel the three registrations from the date of issuance of the order.

Also Read:Unapproved Infertility Drug Enclomiphene Under CDSCO Scanner, States Told to Take Action

The operative portion of the order states:

"The undersigned being the Licensing Authority empowered under Rule 21(b) of the Drugs and Cosmetics Act, 1940, keeping in view the violations of Section 10(b) of the Drugs and Cosmetics Act, 1940, Rule 12 (1), Rule 15 (3), Rule 34 and Rule 35 of the Cosmetics Rules, 2020, and Condition No.3 of Registration Certificate granted by this Directorate, are hereby cancelled the Registration Certificates no. vide RC/COS-005535 dated 25-Oct-2024validuplo24-Ocl-2029, RC/COS-006751 dated 17'Dec-2O25 valid upto 16-Dec-2030 and IRN/COS-,4A/2025/000039 dated 17-Nov-2025 from the date of issue of this order."

To view the official notice, click the link below:

https://medicaldialogues.in/pdf_upload/2026/09/04/cancellation-order-dated-24082026-skintl-enterprises-474194.pdf

cdscoskintl enterprisesCosmeticcosmetic import registrationdrug and cosmetics actcentral licensing authorityonline cosmetics salee commercecosmetics registration certificate

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Print Article